How The Affordable Care Act Ruined Physician-owned Hospitals
The Affordable Care Act celebrated its 13th birthday—mazel tov. It hasn’t been the easiest 13 years, though (my parents also said this to me when I turned 13). The ACA has battled countless lawsuits over the individual and contraception mandates and faced tremendous controversy regarding the actual “affordability” of ACA Marketplace insurance plans. Now, another controversial part of the…Read More
The Resident’s Guide to Personal Finance
I’ve heard countless horror stories about physicians mismanaging their money right from the moment they receive their first residency paycheck. I don’t want this to happen to me or my peers. To address this issue, I’ve spent the past several months studying personal finance and creating a personal finance guide specifically designed for incoming and current…Read More
Is the Future of U.S. Healthcare UnitedHealth Group?
Key healthcare stakeholders like payers, providers, and pharmaceutical services continue to battle harsh economic conditions caused by labor shortages and inflation. As these stakeholders adapt to such conditions, we’re seeing a shift in profit pools. This shift, highlighted by McKinsey’s recent report on the future of U.S. healthcare, speaks to critical profit trends in healthcare. In this…Read More
Are Digital Health Solutions Actually Solutions?
The digital health space is crowded with thousands of digital health companies vying for the attention of consumers, physicians, employers, and insurers. While it was relatively “easy” to capture the attention of consumers and businesses before 2022 (the market was very hot), today’s economic environment is making it more difficult. Now, customers—especially employers—are asking the one question…Read More
Prescription Predicament: How Three New Models are Tackling Drug Prices
The Centers for Medicare and Medicaid Services revealed three experimental models to improve drug affordability and access. Each model is unique, targeting different areas within the drug market that contribute to high drug prices. While these are experimental models, they have the potential to reshape the drug market and improve the patient experience. So, let’s talk about it. In…Read More
Do Weight-management Startups Have a Future?
A version of this story was published first on MedPage Today The effectiveness of GLP-1 agonists—e.g., semaglutide (Wegovy)—in reducing weight has caught nationwide attention, causing a frenzy among celebrities and the wealthy to get their hands on the drug. It has also prompted startups to launch new weight management programs. The weight-management space is the next “big” space. In my opinion,…Read More